Back to results
US 10,376,463 B2Granted
Ocular iontophoretic delivery of dexamethasone and formulations thereof
AssigneeEyeGate Pharmaceuticals, Inc.
InventorsMike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
Life of this patent
Estimating the term…
Abstract
Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
Claims1
An aqueous dexamethasone phosphate formulation comprising:
- (1) dexamethasone phosphate at a concentration of 40 mg/mL;
- and (ii) a buffering agent, wherein said buffering agent adjusts the pH of said formulation to 5.7 to 5.8.
Dependencies are inferred from the claim text.